Clinical Trials Search

Titlesort ascending Intervention NCT ID Sponsor Status
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive... Usual care disease monitoring, Serum Tumor Marker directed disease monitoring, Quality-of-Life Assessment, Anxiety Questionnaire Administration NCT03723928 Southwest Oncology Group Recruiting
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast... Carvedilol, Laboratory Biomarker Analysis, Patient Observation NCT03418961 Southwest Oncology Group Recruiting
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) Preventive Intervention, Quality-of-Life Assessment, Questionnaire Administration NCT02728596 Southwest Oncology Group Active, not recruiting
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and... therapeutic conventional surgery, gastrointestinal complications management/prevention, quality-of-life assessment NCT02270450 Southwest Oncology Group Active, not recruiting
S0820, Adenoma and Second Primary Prevention Trial Eflornithine placebo & sulindac placebo, eflornithine & sulindac placebo, Eflornithine placebo & sulindac, Eflornithine plus sulindac NCT01349881 Southwest Oncology Group Recruiting
Review of Post-Study Clinical Endoscopy Reports in Follow Up to MAY2016-07-01 Electronic Health Record Review NCT04674228 National Cancer Institute (NCI) Recruiting
Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer Retinoid 9cUAB30, Therapeutic Conventional Surgery NCT02876640 National Cancer Institute (NCI) Recruiting
Reproductive Health Program in Patients With Cancer educational intervention, quality-of-life assessment, questionnaire administration NCT01806129 Eastern Cooperative Oncology Group Active, not recruiting
Relaxation for Women With Breast Cancer Undergoing Radiotherapy Relaxation Program, Questionnaires, Saliva Testing NCT01202851 M.D. Anderson Cancer Center Active, not recruiting
Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger... Laboratory Biomarker Analysis, Recombinant Human Papillomavirus Nonavalent Vaccine NCT02568566 National Cancer Institute (NCI) Active, not recruiting

Pages